Press releases

LiveWell Canada announces the interest of the Government of Québec in the financing of its world-class Research and Innovation Centre

Gatineau (Québec), July 26, 2018 – LIVEWELL CANADA INC. (TSX-V:LVWL) (“LiveWell Canada” or the “Company”) greeted favourably the interest of the Government of Québec in participating in the financing of its world-class Research and Innovation Centre in Litchfield, in Pontiac RCM, Québec.

The Government of Québec, through the Ministère de l’Économie, de la Science et de l’Innovation of Québec (MESI) and in collaboration with Investissement Québec, recently sent the Company a letter of interest stating that it is open to contributing up to 25% of the overall financing of the project, subject to terms to be determined in the near future.

The President of LiveWell Canada, Mr. David Rendimonti, expressed his great satisfaction in this offer of collaboration from the Government of Québec. “This is a great step in our quest to develop new therapeutic and medical solutions thanks to a world-class Research and Innovation Centre on hemp and cannabis,” he said.

About LiveWell Canada

LiveWell Canada Inc. (TSX-V:LVWL) is an innovative Canadian company planning to become a leader in a new approach to health and wellness by conducting advanced studies on cannabidiol (CBD) and other cannabinoids in its world-class Research and Innovation Centre located in Litchfield, Québec. The company’s mission also includes developing and distributing prescription and consumer health products. With more than 1.5 million square feet of greenhouses under construction located in Ontario and Québec, the company is supported by renowned academic and business partners such as Canopy Growth (TSX:WEED, NYSE:CGC) and Canopy Rivers. For more information, visit

Cautionary Note Regarding Forward-Looking Statements

This release includes forward-looking statements about the Company and its business. Often, but not always, forward-looking statements can be identified by the use of words such as “plan”, “continue”, “expect”, “schedule”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements (including negative variations) that certain events or conditions “may” or “will” occur. Such statements are based on the current expectations of management. The forward-looking events and circumstances discussed in this release may not occur by certain specified dates or at all and could differ materially as a result of unknown and known risk factors and uncertainties affecting the Company, including risks regarding the cannabis and hemp industry, the possibility that the Company does not receive expected Government support, i.e. 25% of overall financing for the Research and Innovation Centre, economic factors, the equity markets and risks associated with growth and competition. The Company cautions that this foregoing list of material factors is not exhaustive, and readers are encouraged to read all Risk Factors disclosed in the Company’s Filing Statement dated May 29, 2018.

The forward-looking information contained in this press release represents expectations of the Company as of the date of this press release and accordingly, is subject to change after such date. Readers should not place undue importance on forward-looking information and should not rely upon this information as of any other date. While the Company may elect to, it does not undertake to update this information at any particular time except as required in accordance with applicable securities laws.


For more information, visit



Sonya Lord

866 308-1518
[email protected]


Léa Manuel

514 569-7282

[email protected]


Nicole Marchand

416 428-3533

[email protected]

< Back to press releases